| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |